China Prescription Drug 2010 Issue 6 wei chang dao jian zhi liu de ba xiang zhi liao : xian zhuang he wei lai

Home | Survey | Payment| Talks & Presentations | Job Opportunities

Journals A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

China Prescription Drug
1671-945X
2010 Issue 6

wei chang dao jian zhi liu de ba xiang zhi liao : xian zhuang he wei lai
zuo dong ; liang xiao bo

..............page:47-48

ba xiang kang zhong liu yao wu " shi " bu ke dang

..............page:50-51

Quality:The Eternal Theme of Clinical Trials

..............page:20-23

Effects of Anti-diabetic Drugs on Cardiovascular Events
ren xiao mei ; liu nai feng

..............page:37-39

shi xing xin lv shi chang zhen duan he zhi liao jin zhan
cao ke jiang

..............page:33-34

Look Into Gastrointestinal Stromal Tumor
wan de sen

..............page:40-41

ba xiang yao wu liao xiao ping jia biao zhun zuo dai geng xin
na yan qun

..............page:17

qian tan pin pai fu wu dui ti gao xiao fei zhe man yi du de zuo yong
liu song xian

..............page:64

yan zheng xing chang bing zhan mo mian yi ji zhi zhang ai yu ba xiang xing sheng wu xue liao fa
zheng jia ju

..............page:66-69

fei bu gan ran xin yao : xi ru xing an qu nan

..............page:55

Legal Risks Faced by Obstetrics and Gynecology and Prevention
deng xiao hua

..............page:62-63

ying wen zhai yao

..............page:72

wei chang dao jian zhi liu de bing li zhen duan
lin han liang

..............page:42-43

nao mo yan qiu jun xin yi miao :menveo

..............page:54

jiao gan shen jing yi zhi ji ke neng cheng wei xin de ma zui cheng fen
an jian xiong

..............page:16

lin chuang shi yan yao wu jing jie , xu jing zhong chang ming

..............page:24-26

wei chang dao jian zhi liu de wai ke zhi liao yuan ze
lu zhen hai ; wan de sen

..............page:44-46

zuo shi xin wai mo dian ji zai xin zang zai tong bu zhi liao zhong de ying yong yi li bing li fen xi
ren shu jing ; wu li qun ; chen ying ; shen yong chu ; gu gang

..............page:35-36

The Current Status of Dronedarone in Drug Treatment of Atrial Fibrillation
li shi jun ; yang yan zong

..............page:30-32

The Background for Abbot to Tap into Generic Market

..............page:13

Efficient Communication of Industry and CDE in New Drug Development
yang zhi min

..............page:27-29

Preliminary Exploration on the Building of Clinical Trial Institutions
hong ming huang

..............page:10-11

arb lei yao wu zao yu ai zheng feng xian men zuo zuo fen xi zai yin zheng duan an quan xing ping jia mian lin kao yan

..............page:12

Common Problems in Clinical Trial Safety Reporting
fan da chao

..............page:70-71

xin xi dong tai

..............page:6-8,14-15,18-19,49,52-53,56-60

ba wo yao pin sheng ming xian

..............page:2